Review on spectroscopic analytical methods for determination of metformin hydrochloride

Metformin hydrochloride, chemically 1, 1-dimethyl biguanide hydrochloride is a white crystalline powder, hygroscopic and freely soluble in water, used as a hypoglycemic drug: molecular formula C4H11N5.HCL [1-2] structural formula of metformin drug show in figure 1. The name "Metformin" is the BAN, USAN and INN for the medication. It is offered beneath a number of trade names, which include Glucophage XR, Carbophage SR, Riomet, Fortamet, Glumetza, Obimet, Gluformin, Dianben, Diabex, Diaformin, Siofor, Metfogamma and Glifor. It is used as an antihyperglycemic (antihyperglycemic) and for the treatment of kind 2 diabetes according to the World Health Organization (WHO) which often influences those over the age of forty years as properly as in addition to extraordinary age agencies induced by insulin deficiency due to the presence of weakness in the beta cells) in The pancreas, which secretes insulin or as an end result of the introduction of sites in the body, or because of insufficient resistance to insulin receptors, especially in humans with weight problems [3-7] considering it works to counter insulin resistance, in particular in the liver and skeletal muscles, and increases the sensitivity of the insulin surrounding in some tissues Like muscles, and tissues Lipomas works on the oxidation of fatty acids and promotes decomposition of peripheral glucose [8-10]. Metformin was once first synthesized in the 1920, because of a want for a drug that diminished blood sugar levels. After that, he disregarded this drug for two decades, with research pastime in insulin and other anti-diabetic drugs. Then manufacturing of metformin flourished in late 1940, after various reports proved that it may want to lead to low blood sugar. In 1957, the French medical doctor Jean Stern, published the first clinical trial of metformin as a therapy for diabetics. It was produced in the United Kingdom in 1958, in Canada in 1972, and in the United States in 1995, and it is believed to be the most extensively prescribed medication in the world. [11-12].

[1]  F. A. Siddiqui,et al.  Concurrent determination of Metformin and some ACE inhibitors: Its application to Pharmacokinetics , 2017 .

[2]  D. Michel,et al.  Development and validation of fast and simple flow injection analysis-tandem mass spectrometry (FIA-MS/MS) for the determination of metformin in dog serum. , 2015, Journal of pharmaceutical and biomedical analysis.

[3]  Issam M. A. Shakir,et al.  Continuous Flow Injection Analysis (CFIA) of Metformin Hydrochloride using Microphotmeter Equipped with 530 and 550nm LED , 2013 .

[4]  E. Uçaktürk,et al.  The development and validation of a gas chromatography-mass spectrometry method for the determination of metformin in human plasma , 2013 .

[5]  H. Aboul‐Enein,et al.  Miniaturized ionophore-based potentiometric sensors for the flow-injection determination of metformin in pharmaceutical formulations and biological fluids. , 2012, The Analyst.

[6]  R. Day,et al.  Clinical Pharmacokinetics of Metformin , 2011, Clinical pharmacokinetics.

[7]  D. Brocks,et al.  Determination of metformin in human plasma and urine by high-performance liquid chromatography using small sample volume and conventional octadecyl silane column. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[8]  V. Lazǎr,et al.  N,N-dimethylbiguanide complexes displaying low cytotoxicity as potential large spectrum antimicrobial agents. , 2010, European journal of medicinal chemistry.

[9]  A. Donker,et al.  Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial , 2010, BMJ : British Medical Journal.

[10]  N. Sultana,et al.  Spectrophotometric Quantitation of Metformin in Bulk Drug and Pharmaceutical Formulations using Multivariate Technique , 2009, Indian journal of pharmaceutical sciences.

[11]  S. Krähenbühl,et al.  Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia , 2008, Diabetes Care.

[12]  Xu Bai,et al.  Rapid and sensitive liquid chromatography-tandem mass spectrometric method for the quantitation of metformin in human plasma. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  Pgce CBiol Honorary Senior Fellow C Day PhD,et al.  Metformin: its botanical background , 2004 .

[14]  H. Kusuhara,et al.  Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. , 2003, Molecular pharmacology.

[15]  Zhouping Wang,et al.  Sensitive Flow-Injection Chemiluminescence Determination of Metformin Based on N -Bromosuccinimide-fluorescein System , 2003 .

[16]  Miaoli Zhu,et al.  Bis(1,1-di­methyl­biguanido)­nickel(II) , 2002 .

[17]  G. Levy,et al.  Pharmacokinetics of Metformin Gastric‐Retentive Tablets in Healthy Volunteers , 2001, Journal of clinical pharmacology.

[18]  A. Hoffman,et al.  Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[19]  T. Dornan,et al.  Double-Blind Evaluation of Efficacy and Tolerability of Metformin in NIDDM , 1991, Diabetes Care.

[20]  Arthur I. Vogel,et al.  Vogel's Textbook of Quantitative Chemical Analysis , 1989 .

[21]  P. Chaitanya,et al.  SIMULTANEOUS DETERMINATION OF METFORMIN HYDROCHLORIDE AND LINAGLIPTIN BY RP-HPLC IN BULK AND PHARMACEUTICAL FORMULATIONS , 2014 .

[22]  Issam M. A. Shakir,et al.  Continuous Flow Injection Analysis for The Photometric Determination of Metformin Drug Via The Release of Copper(II) ion from Charged Gel Bead Crystal , 2013 .

[23]  Nief R. Ahmed نايف رزاق احمد,et al.  Spectrophotometric determination of metformin hydrochloride via oxidative coupling reaction with 1-naphthol in pharmaceutical and environmental water sample , 2012 .

[24]  L. Kennedy,et al.  Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyRossing P, Pedersen O, Rossing K, et al (Steno Diabetes Ctr, Gentofte, Denmark; Univ of Aarhus, Denmark) Diabetes Care 29:1024–1030, 2006§ , 2007 .

[25]  C. Bailey,et al.  Accumulation of metformin by tissues of the normal and diabetic mouse. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.